MIM is now part of GE HealthCare's portfolio (April 2024)

Global provider of enterprise (content management) software with a range of cloud-based technologies, solutions and services. More than half of Fortune 100 companies are customers. Promoted and assumed team leadership/strategic direction of the Hyland industry portfolio, oversight of 3 Business Delivery Units (BDU’s) comprised of product management (14 remote direct reports) working cross functionally with engineering (~340 resources) and commercial teams to deliver solutions.• Expanded product management discipline, process and structure to all verticals (Financial Services, Government, Insurance, etc.) based on the success of healthcare. • Owned strategy for investment in cloud/SaaS solutions, managing the business case and partnering with senior leaders to drive priorities and manage both organic growth investments and potential acquisitions to accelerate success.• Developed and grew strategic partnerships with vertical and horizontal ecosystem partners and enabled a select number as a route-to-market.• Maintained deep relationships with key enterprise customers and partners at the executive level. Represented the franchise at conferences and with industry analysts.• Notable product accolades: 2022 Gartner Peer Insights “Customers’ Choice”, 2022 Workday Partner Innovation Award (HCM Category).

Recruited to create long-term strategic vision, roadmap and identity for healthcare vertical. Introduced and scaled product management function, best practices and performance metrics. Accelerated development, partnerships and acquisitions.• Formulated and executed strategic plan to grow the healthcare vertical by $100M in sales in 3 years (starting in Q4 ’18). Efforts included transitioning product and pricing to a subscription (SaaS) model, integrating 3 new acquisitions into one simplified platform and establishing a value proposition for offering.• Expanded relationships with ecosystem partners like Epic (38+ module integrations), Nuance (dictation/reporting), Amazon AWS (cloud, intelligent document processing), 3M (coding & reimbursement), Optos (zero footprint viewer), Workday (HR), Salesforce (CRM).• Structured customer advocacy/feedback programs: coordinated 3 advisory councils; co-created the limited availability (LA) program; aligned dev teams to values streams/customer outcomes.• Provided coaching/development opportunities for team leads and direct reports. 2 resources promoted to BDU lead/senior manager in 2022.• Notable product accolades: 2022 IDC Marketscape “Major Player” (US Enterprise Imaging, ’22-23), 2021 Gartner Magic Quadrant (Content Services), 2020 Frost & Sullivan North American Product Leadership Award, HIMSS Enterprise Davies Award (in partnership with NYU Langone Health)

Cleveland Clinic Representative

Cleveland Clinic Representative

CCI is the commercialization arm of Cleveland Clinic. 95 spin-off companies have been enabled by Cleveland Clinic technology receiving nearly $1.4B+ in equity investment to date. CCI has transacted over 700+ royalty bearing licenses.Exposure to a multitude of technologies: Digital surgery/robotics, imaging/navigation, neurostimulation, endoscopic tools/devices (stents/grafts, balloons, biopsy retrieval, ablation, etc.), ortho fixation, drug delivery, telemetry/remote monitoring, digital apps (chronic care, disease tracking), biotech/diagnosticsCommercialization Director, Medical Device | 2015 to 2018 Promoted and assumed oversight of CC’s medtech portfolio. Managed/mentored 6 direct reports tasked with evaluating, developing and monetizing IP originating from staff physicians/surgeons. • Established revenue targets and corresponding strategic and tactical initiatives to ensure goals were met. FY16: 12% growth YOY.• Served as advisor/board representative for CC new ventures providing product & go-to-market insight. • Formed, fostered and appropriately leveraged relationships with hospital Key Opinion Leaders (KOLs), physicians, administrators, researchers, etc.• Proactively monitored market trends, gathered voice-of-customer insights and collaborated with industry partners to identify opportunities for new innovation and shared revenue.Senior Innovations Officer, Neurological Institute | 2013 to 2015 Accountable for achieving revenue targets within assigned territory (neurology/spine).• FY 2015: 105% to plan – new license contracts; FY 2014: $5M on $300K plan; Secured $750K in funding for stroke rehab/ neurostimulation venture; FY 2013: Sourced, negotiated and executed 2 contracts; Grew overall leads by 50% YOY via outreach activities.• Facilitated Peer Review Board with institute chairmen, surgeons, engineering, and supply chain to evaluate the clinical usefulness and economic value of product concepts.

$1.5B medical device company focusing on orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery technologiesFull P&L responsibility for 16 products (spine implants). Led the Top 3 initiatives in '12.• Launched a novel minimally invasive surgical procedure/technique utilizing navigation. Spearheaded growth within anterior/lateral lumbar fusion segment (+25%, record $535K sales in June ‘11).• Designed and delivered regionally aligned marketing programs (US market); partnered with clinical resources and design surgeons to administer professional education programs (case observations, hands-on training, physician onboarding)• Supported sales (distributor model) by participating in activities aimed at converting or retaining key surgeons. Spent >50% of my time in the field• Established strategic plan by category. Activities included revenue forecasting, budgeting, product life cycle and competitive analysis

$4.6B global leader in infection prevention, contamination control, surgical and critical care technologiesResponsible for the strategic development of 4 product lines with combined revenues of $104M. • Directed worldwide launch of the V-PRO™ 1 Low Temperature Sterilizer, growing sales from $0 to $18.3M in 15 months. Captured 19% market share from main competitor, Johnson & Johnson – Advanced Sterilization Products. Unit placements in 22 countries. • Exceeded FY2008 plan by 58%, FY2009 by 10%• Devised the V-PRO 1 marketing plan; directly responsible for training, coaching and motivating 120+ sales representatives in various geographies (N. America, Europe, Latin America, Asia-Pacific); Reached 2,000+ key decision makers with a comprehensive promotional campaign.• Initiated a service technician lead generation program resulting in a $6.8M return on a $20K investment.

$1B global leader in the home and long-term care industriesManaged $7M wheelchair accessory product line and $6M personal mobility vehicle product line respectively; supervised Associate Product Manager direct report• Responsibilities included: financial P&L, new product development and introduction, existing product portfolio management, pricing and profitability, marketing programs, distribution, training and education • Stabilized underperforming seating product line which had previously been decreasing by $2M in sales per year since 2002. Profit before tax was 104% to 2006 annual operating plan• Developed new identity for line of seating products; incorporated new branding (InTouch™) and technology as core elements; introduced first product in July 2005 with 4 additional models that launched in September 2006• Created sales incentive program with an ROI of 1935% that grew sales by 16% in Q2 of '06

Established leader in automation solutions with over 900 employees in 9 locations, including Cleveland, Boston, Houston, Raleigh, Atlanta, Thousand Oaks/Los Angeles, Southeast Asia (Singapore, Thailand) and Europe (the Netherlands)• Defined, developed and launched 5 new products generating $50K in annual revenue• Successfully implemented 10 information integration software solutions ($1.5M in revenue); coordinated cross-functional groups up to 10 people• Routinely managed projects on schedule and 10-20% under budget• Provided strategic direction and customer feedback to R&D to improve upon product performance; reduced development process time by 25%• Developed training material (procedure manuals, product features/benefits) and facilitated training programs for internal sales force and for product end users